Bionano Genomics Stock Forecast - Naive Prediction
| BNGO Stock | USD 0.26 0.02 8.33% |
The Naive Prediction forecasted value of Bionano Genomics on the next trading day is expected to be 0.24 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 1.18. Bionano Stock Forecast is based on your current time horizon. Although Bionano Genomics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Bionano Genomics' systematic risk associated with finding meaningful patterns of Bionano Genomics fundamentals over time.
Bionano |
Bionano Genomics Cash Forecast
Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Bionano Genomics' financial statements to estimate their effects on upcoming price movements.
Cash | First Reported 2016-12-31 | Previous Quarter 21.4 M | Current Value 8.8 M | Quarterly Volatility 87.6 M |
Bionano Genomics Naive Prediction Price Forecast For the 3rd of December
Given 90 days horizon, the Naive Prediction forecasted value of Bionano Genomics on the next trading day is expected to be 0.24 with a mean absolute deviation of 0.02, mean absolute percentage error of 0.0005, and the sum of the absolute errors of 1.18.Please note that although there have been many attempts to predict Bionano Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Bionano Genomics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Bionano Genomics Stock Forecast Pattern
| Backtest Bionano Genomics | Bionano Genomics Price Prediction | Buy or Sell Advice |
Bionano Genomics Forecasted Value
In the context of forecasting Bionano Genomics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Bionano Genomics' downside and upside margins for the forecasting period are 0 and 5.56, respectively. We have considered Bionano Genomics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Bionano Genomics stock data series using in forecasting. Note that when a statistical model is used to represent Bionano Genomics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 110.5644 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0193 |
| MAPE | Mean absolute percentage error | 0.0578 |
| SAE | Sum of the absolute errors | 1.1757 |
Predictive Modules for Bionano Genomics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bionano Genomics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Bionano Genomics
For every potential investor in Bionano, whether a beginner or expert, Bionano Genomics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Bionano Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Bionano. Basic forecasting techniques help filter out the noise by identifying Bionano Genomics' price trends.View Bionano Genomics Related Equities
| Risk & Return | Correlation |
Bionano Genomics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Bionano Genomics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Bionano Genomics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Bionano Genomics Market Strength Events
Market strength indicators help investors to evaluate how Bionano Genomics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bionano Genomics shares will generate the highest return on investment. By undertsting and applying Bionano Genomics stock market strength indicators, traders can identify Bionano Genomics entry and exit signals to maximize returns.
Bionano Genomics Risk Indicators
The analysis of Bionano Genomics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Bionano Genomics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bionano stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.14 | |||
| Standard Deviation | 5.29 | |||
| Variance | 28.03 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Bionano Genomics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bionano Genomics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionano Genomics will appreciate offsetting losses from the drop in the long position's value.Moving together with Bionano Stock
| 0.69 | A | Agilent Technologies Sell-off Trend | PairCorr |
| 0.9 | ME | 23Andme Holding Upward Rally | PairCorr |
| 0.84 | VALN | Valneva SE ADR | PairCorr |
Moving against Bionano Stock
| 0.86 | DRUG | Bright Minds Biosciences Trending | PairCorr |
| 0.78 | VCYT | Veracyte | PairCorr |
| 0.72 | VERA | Vera Therapeutics | PairCorr |
| 0.59 | VANI | Vivani Medical | PairCorr |
| 0.54 | VCEL | Vericel Corp Ord | PairCorr |
The ability to find closely correlated positions to Bionano Genomics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bionano Genomics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bionano Genomics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bionano Genomics to buy it.
The correlation of Bionano Genomics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bionano Genomics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bionano Genomics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bionano Genomics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Bionano Genomics to cross-verify your projections. To learn how to invest in Bionano Stock, please use our How to Invest in Bionano Genomics guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bionano Genomics. If investors know Bionano will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bionano Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.30) | Revenue Per Share 0.749 | Quarterly Revenue Growth (0.10) | Return On Assets (0.33) | Return On Equity (1.38) |
The market value of Bionano Genomics is measured differently than its book value, which is the value of Bionano that is recorded on the company's balance sheet. Investors also form their own opinion of Bionano Genomics' value that differs from its market value or its book value, called intrinsic value, which is Bionano Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bionano Genomics' market value can be influenced by many factors that don't directly affect Bionano Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bionano Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bionano Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bionano Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.